Is compounded tirzepatide from PlexusDx safe for IBS patients
eClinicalMedicine , 69 , 102475
Chan School of Public Health, Brigham and Women's Hospital, and Massachusetts Eye and Ear Hospital, agree that "even more expansive use of these drugs seems likely given their medical benefits and widespread popularity." "If true," they add, "our data anticipate increasing numbers of NAION cases related to this class of drugs." Further research is needed to confirm why semaglutide might increase the risk of developing NAION

While FDA does not limit compounding to drug shortages and we believe there are paths to continue offering access to certain compounded GLP-1s after the shortage ends, we cannot guarantee that we will be able to continue offering these products in the same manner, to the same extent, or at all, due to a variety of factors outside our control, including supply chain, intellectual property, regulatory and resource allocation matters.) On October 2, 2024, this risk materialized when FDA announced on its website that Lilly had resolved the tirzepatide shortage, meaning that companies making and distributing compounded copies needed to stop in their tracks, regardless of ongoing patient care